Abstract
Among pneumococci with decreased susceptibility or pneumococci resistant to penicillin (PRP) isolated at Armand-Trousseau children's hospital, those expressing capsular serotypes 23F, 9V, and 14 were the most frequently isolated. We compared 53 clinical isolates (14 type 9V, 26 type 23F, and 13 type 14) by analysis of chromosomal macrorestriction patterns and DNA restriction patterns of the penicillin-binding protein (PBP) genes pbp 2b, pbp 2x, and pbp 1a. All 9V isolates originated from the same clone. Five 23F clones were distinguished, the largest of which comprised 20 isolates. The main type 14 clone comprised nine isolates; three other type 14 strains were closely related to the 9V clone, probably by horizontal transfer of capsular biosynthesis genes. Most 23F and type 14 isolates shared the same PBP gene restriction patterns as the 9V clone, suggesting horizontal transfer of altered PBP genes.
References
Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R MunozA Tomasz
Jul 1, 1992·Journal of Bacteriology·C MartinR Hakenbeck
Aug 1, 1991·Molecular Microbiology·G LaibleR Hakenbeck
Sep 1, 1991·Molecular Microbiology·T J CoffeyJ M Musser
Aug 1, 1991·The Journal of Infectious Diseases·R MuñozB G Spratt
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C G DowsonB G Spratt
Oct 1, 1989·Molecular Microbiology·G LaibleJ M Ghuysen
Jan 1, 1989·Molecular Microbiology·C G DowsonB G Spratt
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C G DowsonB G Spratt
Sep 1, 1995·Journal of Clinical Microbiology·F C TenoverB Swaminathan
Sep 1, 1993·Antimicrobial Agents and Chemotherapy·A M SmithB G Spratt
Oct 1, 1993·Journal of Clinical Microbiology·J C LefevreA M Gasc
Citations
Jul 10, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·R B RobertsUNKNOWN PRP Collaborative Study Group
Jul 10, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M C VelaE Castañeda
Nov 18, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·E CastañedaA Tomasz
Nov 18, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A RossiA Tomasz
Jul 11, 1998·Journal of Clinical Pathology·L M Hall
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·K NagaiP C Appelbaum
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Jean-Winoc DecousserUNKNOWN ColBVH Study Group
Aug 23, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·B SenerO Eser
Oct 31, 1998·Antimicrobial Agents and Chemotherapy·G A PankuchP C Appelbaum
May 1, 1999·Antimicrobial Agents and Chemotherapy·T A DaviesP C Appelbaum
Aug 9, 2003·Journal of Clinical Microbiology·D BennettM Cafferkey
Sep 6, 2003·Journal of Clinical Microbiology·Robert E GertzBernard Beall
Jun 10, 1998·Journal of Clinical Microbiology·L M Hall, B Duke
Jun 28, 2001·Journal of Clinical Microbiology·L McGeeK P Klugman
Feb 13, 1999·Journal of Clinical Microbiology·L Setchanova, A Tomasz
Dec 17, 1998·Journal of Clinical Microbiology·P R HsuehK T Luh
Jan 5, 2000·Journal of Clinical Microbiology·H Y TsaiK T Luh